Citigroup Inc Embecta Corp. Transaction History

Citigroup Inc

$163 Billion
Q4 2024

A detailed history of Citigroup Inc transactions in Embecta Corp. stock. As of the latest transaction made, Citigroup Inc holds 90,097 shares of EMBC stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

90,097

Previous 79,284 13.64%

Holding current value

$1.2 Million

Previous $1.12 Million 67.5%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$12.51 - $20.83 $135,270 - $225,234	10,813 Added 13.64%	90,097 $1.87 Million
Q3 2024 Nov 12, 2024	BUY	$11.46 - $16.56 $428,695 - $619,476	37,408 Added 89.33%	79,284 $1.12 Million
Q2 2024 Aug 12, 2024	BUY	$10.13 - $14.6 $51,126 - $73,686	5,047 Added 13.7%	41,876 $523,000
Q1 2024 May 10, 2024	SELL	$12.35 - $19.33 $115,213 - $180,329	-9,329 Reduced 20.21%	36,829 $488,000
Q4 2023 Feb 09, 2024	BUY	$12.87 - $19.09 $218,043 - $323,422	16,942 Added 57.99%	46,158 $873,000
Q3 2023 Nov 09, 2023	SELL	$15.0 - $22.17 $285,495 - $421,961	-19,033 Reduced 39.45%	29,216 $439,000
Q2 2023 Aug 10, 2023	BUY	$21.6 - $30.69 $427,852 - $607,907	19,808 Added 69.65%	48,249 $1.04 Million
Q1 2023 May 11, 2023	SELL	$23.07 - $32.77 $177,800 - $252,558	-7,707 Reduced 21.32%	28,441 $799,000
Q4 2022 Feb 09, 2023	BUY	$25.29 - $35.48 $176,600 - $247,756	6,983 Added 23.94%	36,148 $914,000
Q3 2022 Nov 10, 2022	BUY	$24.0 - $33.42 $26,784 - $37,296	1,116 Added 3.98%	29,165 $839,000
Q2 2022 Aug 10, 2022	BUY	$24.78 - $33.36 $694,261 - $934,647	28,017 Added 87553.13%	28,049 $710,000
Q1 2022 May 12, 2022	BUY	$33.33 - $47.0 $1,066 - $1,504	32 New	32 $1,000

Others Institutions Holding EMBC

# of Institutions

405

Shares Held

52.4M

Call Options Held

120K

Put Options Held

66.8K

View Full List

About Embecta Corp.

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $770M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

More about EMBC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account